Abstract:Objective We aim to quantify whole‐brain tissue property changes in patients with MRI‐negative pharmacoresistant focal epilepsy by 3D magnetic resonance fingerprinting (MRF). Methods We included 30 patients with pharmacoresistant focal epilepsy and negative MRI by official radiology report, as well as 40 age‐and‐gender‐matched healthy controls (HCs). MRF scans were obtained with 1mm3 isotropic resolution. Quantitative T1 and T2 relaxation maps were reconstructed from MRF and registered to the MNI space. A two‐sample t‐test was performed in Functional Magnetic Resonance Imaging of the Brain (FMRIB) Software Library (FSL) to evaluate significant abnormalities in patients comparing to HCs, with correction by the threshold‐free cluster enhancement (TFCE) method. Subgroups analyses were performed for ETLE/TLE, and for those with/without subtle abnormalities detected by morphometric analysis program (MAP), to investigate each subgroup's pattern of MRF changes. Correlation analyses were performed between the mean MRF values in each significant cluster and seizure‐related clinical variables. Results Compared to HCs, patients exhibited significant group‐level T1 increase ipsilateral to the epileptic origin, in the mesial temporal gray matter (GM) and white matter (WM), temporal pole GM, orbitofrontal GM, hippocampus, amygdala, with scattered clusters in the neocortical temporal and insular GM. No significant T2 changes were detected. The ETLE subgroup showed T1 increase pattern similar to the overall cohort, with additional involvement of the ipsilateral anterior cingulate GM. The subgroup of MAP+ patients also showed T1 increase pattern similar to the overall cohort, with additional cluster in the ipsilateral lateral orbitofrontal GM. Higher T1 was associated with younger seizure‐onset age, longer epilepsy duration and higher seizure frequency. Significance MRF revealed group‐level T1 increase in limbic/paralimbic structures ipsilateral to the epileptic origin, in patients with pharmacoresistant focal epilepsy and no apparent lesions on the MRI, suggesting these regions may be commonly affected by seizures in the epileptic brain. The significant association between T1 increase and higher seizure burden may reflect progressive tissue damage.

MRI-negative Refractory Partial Epilepsy: Role for Diffusion Tensor Imaging in High Field MRI

Linking Mri Postprocessing with Magnetic Source Imaging in Mri-Negative Epilepsy

7T MRI with Post-Processing for the Presurgical Evaluation of Pharmacoresistant Focal Epilepsy.

Evaluating Whole‐brain Tissue Property Changes in MRI‐negative Pharmacoresistant Focal Epilepsies using MR Fingerprinting

Preliminary Study of MR Diffusion Tensor Imaging in Lateralizing Temporal Lobe Epilepsy

Preliminary Application of Voxel-based Diffusion Tensor Imaging in Mesial Temporal Lobe Epilepsy

Diffusion and Volumetry Abnormalities in Subcortical Nuclei of Patients with Absence Seizures.

2D-MRSI and DTI in Pediatric Frontal Lobe Epilepsy with Negative MRI Findings

Investigation of Altered Microstructure in Patients with Drug Refractory Epilepsy Using Diffusion Tensor Imaging

Application of Diffusion Tensor Imaging to Idiopathic Generalized Epilepsy

Structural and functional alterations in MRI-negative drug-resistant epilepsy and associated gene expression features

Combined diffusion tensor imaging and quantitative susceptibility mapping to characterize normal-appearing white matter in self-limited epilepsy with centrotemporal spikes

Detecting Epileptogenic Focus by Brain Diffusion Imaging after Injection of Flumazenil

The Diagnostic Value of 18F-FDG PET/MRI in MR-positive Refractory Epilepsy

The neural function analysis based on PET/CT localization of the MRI negative epilepsy The neural function analysis based on PET/CT localization of the MRI negative epilepsy

Localizing Epileptic Foci Before Surgery in Patients With MRI-Negative Refractory Epilepsy Using Statistical Parameter Mapping and Three-Dimensional Stereotactic Surface Projection Based on 18F-FDG PET

Relationship of Cognitive Function with MRI and DTI in Patients with Temporal Lobe Epilepsy

Lateralization of Temporal Lobe Epileptic Foci with Automated Chemical Exchange Saturation Transfer Measurements at 3 Tesla.

Characterizing Thalamic and Basal Ganglia Nuclei in Medically Intractable Focal Epilepsy by MR Fingerprinting

Thalamocortical structural connectivity abnormalities in drug-resistant generalized epilepsy: A diffusion tensor imaging study

Diffusion-weighted magnetic resonance imaging demonstrates parenchymal pathophysiological changes in epilepsy.